Benoit Marteyn Inserm researcher Unit 1202 Molecular Microbial Pathogenesis +33 (0)1 45 68 83 08 email@example.com
Déplétion de l’oxygène au sein de la muqueuse intestinale par Shigella (vert), induisant une hypoxie (rouge) au sein des foyers infectieux inflammatoires (neutrophiles: marqués à l’aide du Myelotracker, bleu). ©Benoit Marteyn/ Inserm/ Institut Pasteur
Bacillary dysentery caused by the intestinal bacteria Shigella is a major health problem in tropical regions and developing countries. Complications from this infection lead to several hundred thousand deaths a year, primarily among infants. Researchers from Inserm and the Institut Pasteur have studied the mechanisms of Shigella virulence. They found that these bacteria are not only able to consume the oxygen in colonic tissue in order to grow and create foci of infection, but can also adapt their mode of respiration so that they can continue to grow once the oxygen in these foci has been used up. These findings, published in Nature Microbiology, open up new prospects for the development of antibiotics and vaccines to combat this group of bacteria, which is on the WHO list of 12 priority pathogens.
Shigella is a group of pathogenic enterobacteria (bacteria found in the digestive tract) that cause bacillary dysentery, which is also known as shigellosis. They are transmitted via the fecal-oral route, for example through food or water contaminated with fecal matter, and are thus primarily endemic in tropical regions, particularly in developing countries where a lack of hygiene and healthcare infrastructure favor outbreaks of disease. After ingestion, Shigella bacteria invade the cells of the intestinal wall and then the colonic mucosa, causing major inflammation combined with severe tissue damage. This causes symptoms such as abdominal pain, vomiting, diarrhea containing blood or mucus, and fever.
With no commercialized vaccine (the infection is currently treated with antibiotics), shigellosis remains a major public health problem, and results in 700,000 deaths per year around the world—primarily among children under the age of 5—from acute complications.
The emergence of new multi-drug resistant strains of Shigella has prompted inclusion of the bacteria on the WHO list of 12 “priority pathogens” for which new treatments (vaccines or antibiotics) are urgently needed.
With this in mind, a team led by Inserm researcher Benoit Marteyn within Unit 1202, “Molecular Microbial Pathogenesis” (Institut Pasteur/Inserm), sought to better understand the mechanism used by Shigella to infect tissue by modulating the levels of oxygen present. To do this, the researchers used innovative image analysis methods developed by the Imagopole at the Institut Pasteur, which allowed them to study each cell individually (single-cell analysis) and monitor variation in the levels of oxygen O2 in intestinal tissues around isolated bacteria and in foci of infection, where bacteria are numerous.
The research group also found that foci of Shigella infection had abnormally low levels of oxygen (hypoxia). The denser the population of bacteria, the greater the consumption of O2. Hypoxia was not, however, seen around isolated bacteria away from the foci of infection.
The researchers have thus shown that aerobic respiration of Shigella and their capacity to modulate the oxygenation of infected tissues enables the formation of hypoxic foci of infection within the intestinal mucosa, which constitutes the first stage in their colonization strategy, with over 99% of the bacterial population growing in these areas. When these foci are depleted of oxygen, the adaptability of the bacteria to O2-poor environments gives them a crucial advantage that explains their virulence and that of other facultative anaerobic enterobacteria.
“These findings are very important in relation to the search for new antibiotics and candidate vaccines to combat Shigella infection. Their mechanisms of action will need to be confirmed in hypoxic or even anoxic conditions, to reflect the pathophysiological conditions in which Shigella primarily grow within the colonic mucosa,” concludes Benoit Marteyn.
La mise au point d’un vaccin préventif contre l’infection par le VIH (virus de l’immunodéficience humaine) est une priorité pour lutter efficacement contre la transmission du virus. Le Vaccine Research Institute (VRI, ANRS-Inserm et Université Paris-Est Créteil) lance une campagne de recrutement ...
Tandis que la campagne de vaccination contre la Covid-19 suit son cours, les efforts de recherche se poursuivent dans les laboratoires afin d’améliorer les vaccins disponibles et de développer de nouveaux candidats, efficaces et innovants pour lutter contre la pandémie et les ...
Shigella-mediated oxygen depletion is essential for intestinal mucosa colonization Jean-Yves Tinevez1,2,11, Ellen T. Arena3,4,9,11, Mark Anderson3,4, Giulia Nigro3,4, Louise Injarabian3,5, Antonin André3,5, Mariana Ferrari3,4, François-Xavier Campbell-Valois3,4,10, Anne Devin5, Spencer L. Shorte1,6, Philippe J. Sansonetti3,4,7,8 and Benoit S. Marteyn3,4,5* 1 UTechS Photonic BioImaging (Imagopole), Institut Pasteur, Paris, France. 2 Image Analysis Hub, Institut Pasteur, Paris, France. 3 Unité de Pathogénie Microbienne Moléculaire, Institut Pasteur, Paris, France. 4 INSERM Unité 1202, Paris, France. 5 IBGC, CNRS UMR 5095, Université Bordeaux, Bordeaux, France. 6 Institut Pasteur Korea, Seongnam, Republic of Korea. 7 Collège de France, Paris, France. 8 Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. 9 Present address: Laboratory for Optical and Computational Instrumentation, University of Wisconsin–Madison, Madison, WI, USA. 10 Present address: Department of Chemistry and Biomolecular Sciences, Faculty of Science, University of Ottawa, Ottawa, Ontario, Canada. 11 These authors contributed equally Nature microbiology : https://doi.org/10.1038/s41564-019-0525-3